Hepatic Venous Pressure Gradient Measurement and its Limitation

被引：0

作者：

Altork, Nadera ^{[1
]}

Peppas, Spyridon ^{[1
]}

Rabiee, Atoosa ^{[2
]}

机构：

[1] Medstar, Washington Hosp Ctr, 110 Irving St, Washington, DC 20010 USA

[2] Washington DC VA Med Ctr, 50 Irving St, Washington, DC 20422 USA

来源：

CURRENT HEPATOLOGY REPORTS | 2025年 / 24卷 / 01期

关键词：

Hepatic venous pressure gradient; Clinically significant portal hypertension; Cirrhosis; PORTAL-HYPERTENSION; PROGNOSTIC VALUE; HEPATOCELLULAR-CARCINOMA; VARICEAL HEMORRHAGE; CLINICAL-USE; CIRRHOSIS; RISK;

D O I：

10.1007/s11901-025-00679-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Purpose of reviewIn this brief review we discuss definition of portal hypertension, how to measure it through hepatic venous pressure gradient as well as its main clinical use.Recent findingsWith the expanding role of non-invasive methods to diagnose and monitor portal hypertension, the role of HVPG measurement has significantly changed. However, there are still significant clinical and research roles that can only be achieved by invasive HVPG measurements.SummaryHVPG measurement is crucial in assessing and developing pharmacological therapies, in addition to its role in clinical practice. However, it has its limitations including availability and invasiveness. Future studies should focus on finding modalities that can be as accurate as HVPG but non-invasive.

引用

页数：8

共 38 条

[1] Guidance document: risk assessment of patients with cirrhosis prior to elective non-hepatic surgery [J].

Abbas, Nadir ;

Fallowfield, Jonathan ;

Patch, David ;

Stanley, Adrian J. ;

Mookerjee, Raj ;

Tsochatzis, Emmanouil ;

Leithead, Joanna A. ;

Hayes, Peter ;

Chauhan, Abhishek ;

Sharma, Vikram ;

Rajoriya, Neil ;

Bach, Simon ;

Faulkner, Thomas ;

Tripathi, Dhiraj .

FRONTLINE GASTROENTEROLOGY, 2023, 14 (05) :359-370

[2] Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension [J].

Abraldes, Juan G. ;

Trebicka, Jonel ;

Chalasani, Naga ;

D'Amico, Gennaro ;

Rockey, Don C. ;

Shah, Vijay H. ;

Bosch, Jaime ;

Garcia-Tsao, Guadalupe .

HEPATOLOGY, 2019, 69 (03) :1287-1299

[3] Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: A systematic review [J].

Alsaeid, Mohammad ;

Sung, Shuen ;

Bai, Wayne ;

Tam, Matthew ;

Wong, Yu Jun ;

Cortes, Jordi ;

Cobo, Erik ;

Gonzalez, Jose Antonio ;

Abraldes, Juan G. .

HEPATOLOGY COMMUNICATIONS, 2024, 8 (02)

[4] Test-Retest Reliability and Consistency of HVPG and Impact on Trial Design: A Study in 289 Patients from 20 Randomized Controlled Trials [J].

Bai, Wayne ;

Al-Karaghouli, Mustafa ;

Stach, Jesse ;

Sung, Shuen ;

Matheson, Granville J. ;

Abraldes, Juan G. .

HEPATOLOGY, 2021, 74 (06) :3301-3315

[5]

Berzigotti A, 2013, EXPERT REV GASTROENT, V7, P141, DOI [10.1586/egh.12.83, 10.1586/EGH.12.83]

[6]

Bochnakova Teodora, 2021, Clin Liver Dis (Hoboken), V17, P144, DOI 10.1002/cld.1031

[7] The clinical use of HVPG measurements in chronic liver disease [J].

Bosch, Jaime ;

Abraldes, Juan G. ;

Berzigotti, Annalisa ;

Carlos Garcia-Pagan, Juan .

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (10) :573-582

[8] Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure [J].

Bruix, J ;

Castells, A ;

Bosch, J ;

Feu, F ;

Fuster, J ;

GarciaPagan, JC ;

Visa, J ;

Bru, C ;

Rodes, J .

GASTROENTEROLOGY, 1996, 111 (04) :1018-1022

[9] One size does not fit all: Differential benefits of simultaneous liver-kidney transplantation by eligibility criteria [J].

Cheng, Xingxing S. ;

Mcelroy, Lisa M. ;

Sanoff, Scott L. ;

Kwong, Allison J. .

LIVER TRANSPLANTATION, 2023, 29 (11) :1208-1215

[10] Baveno VII - Renewing consensus in portal hypertension [J].

de Franchis, Roberto ;

Bosch, Jaime ;

Garcia-Tsao, Guadalupe ;

Reiberger, Thomas ;

Ripoll, Cristina .

JOURNAL OF HEPATOLOGY, 2022, 76 (04) :959-974

← 1 2 3 4 →